Qingdao Vland Biotech INC. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 535.59 million compared to CNY 514.05 million a year ago. Revenue was CNY 543.94 million compared to CNY 532.6 million a year ago.

Net income was CNY 31.47 million compared to CNY 37.41 million a year ago. Basic earnings per share from continuing operations was CNY 0.12 compared to CNY 0.15 a year ago. Diluted earnings per share from continuing operations was CNY 0.12 compared to CNY 0.15 a year ago.